2Kharasch E D,Novak R F.Mitoxantrone and ametantrone inhibit hydroperoxide-dependent initiation and propagation reactions infatty acid peroxidation[J].Biol Chem,1985,260:10645.
1Jain KK. Neuroprotection in cerebrovascular disease. Expert Opin Investig Drugs, 2000,9:695
2Tanaka M. Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent. Nippon Yakurigaku Zasshi, 2002, 119:301
3Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis, 2003, 15:222
4Tabrizchi R. Edaravone Mitsubishi-Tokyo. Curr Opin Investig Drugs, 2000,1:347
5Jin YJ, Mima T, Raicu V, et al. Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils. Neurosci Res, 2002,43:75
6Tanahashi N, Fukuuchi Y. Treatment of acute ischemic stroke: recent progress. Intern Med, 2002, 41:337
7Bell T, Komgable G, Steinbery G, et al.Mild hypothermia An alternative to deep hypothermia lier acheving neuroprotection. J cardiovas Nurs, 1998,13 ( 1 ): 34-44.
8Georgiadis B, Schwarz S, Aschoff A, et al.Hemicraniectomy andmoderate hypothermis in patients with severe ischemic stroke. Stroke,2002,33(2): 1584-1588.
9During M,Symes C,Lawlor P,et al. An oral vaccine against NMDAR1 with efficacy in experimenral stroke and epilepsy. Science, 2000,287 (5457): 1453-1460.
10Albers GW, Goldstein LB, Hall L, et al.Aptiganel hydrochloride in acute ischemic stroke. J American Medicine Association,2001,286 (21 ): 2673-2682.
